Bernardi Rick E, Spanagel Rainer
Institute of Psychopharmacology, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, J5, 68159 Mannheim, Germany.
Institute of Psychopharmacology, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, J5, 68159 Mannheim, Germany.
Behav Brain Res. 2014 Dec 15;275:11-4. doi: 10.1016/j.bbr.2014.08.048. Epub 2014 Sep 1.
Sensitization to the locomotor activating effect of drugs of abuse occurs following repeated exposure to a drug, and/or when limited exposure to a drug is paired with a specific environment. Conditioned, or context-dependent, sensitization has been well-characterized using limited exposure protocols in, for example, cocaine- and amphetamine-treated animals. However, little data exists regarding limited exposure protocols for other drugs of abuse, such as nicotine. The current experiment investigated whether a two-injection protocol of nicotine administration would result in locomotor sensitization. Mice administered two injections of nicotine (0.175mg/kg, s.c.) 7d apart demonstrated significant locomotor sensitization in response to the second exposure. Furthermore, the development of this sensitization was blocked by the administration of the nicotinic acetylcholine receptor antagonist mecamylamine (2mg/kg) prior to the first nicotine exposure. In a follow-up study, we found that this two-injection nicotine sensitization was independent of context, as separate groups of mice given an initial nicotine exposure (0.175mg/kg, s.c.) in either the specific environment in which locomotor activity was tested or in their home cages demonstrated equivalent levels of locomotor activity during subsequent testing 7d later. These data suggest a novel approach to nicotine sensitization using limited nicotine exposure.
对滥用药物的运动激活作用产生敏化作用,是在反复接触某种药物之后,和/或当有限接触某种药物与特定环境配对时发生的。例如,在可卡因和苯丙胺处理的动物中,使用有限接触方案已对条件性或情境依赖性敏化作用进行了充分表征。然而,关于其他滥用药物(如尼古丁)的有限接触方案的数据很少。当前实验研究了尼古丁给药的两次注射方案是否会导致运动敏化。相隔7天接受两次尼古丁注射(0.175mg/kg,皮下注射)的小鼠,在第二次接触时表现出显著的运动敏化。此外,在首次接触尼古丁之前给予烟碱型乙酰胆碱受体拮抗剂美加明(2mg/kg)可阻断这种敏化作用的发展。在一项后续研究中,我们发现这种两次注射尼古丁的敏化作用与情境无关,因为在测试运动活动的特定环境中或在其笼舍中接受初始尼古丁暴露(0.175mg/kg,皮下注射)的不同组小鼠,在7天后的后续测试中表现出同等水平的运动活动。这些数据表明了一种使用有限尼古丁暴露进行尼古丁敏化的新方法。